- Home
- ICCM vs NMTC Comparison
ICCM vs NMTC Comparison
Compare ICCM & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- NMTC
- Stock Information
- Founded
- ICCM 2006
- NMTC 2009
- Country
- ICCM Israel
- NMTC United States
- Employees
- ICCM N/A
- NMTC N/A
- Industry
- ICCM
- NMTC Medical/Dental Instruments
- Sector
- ICCM
- NMTC Health Care
- Exchange
- ICCM Nasdaq
- NMTC Nasdaq
- Market Cap
- ICCM 56.2M
- NMTC 45.0M
- IPO Year
- ICCM N/A
- NMTC N/A
- Fundamental
- Price
- ICCM $0.84
- NMTC $0.81
- Analyst Decision
- ICCM Strong Buy
- NMTC Strong Buy
- Analyst Count
- ICCM 1
- NMTC 2
- Target Price
- ICCM $2.50
- NMTC $2.23
- AVG Volume (30 Days)
- ICCM 2.3M
- NMTC 515.8K
- Earning Date
- ICCM 11-25-2025
- NMTC 08-14-2025
- Dividend Yield
- ICCM N/A
- NMTC N/A
- EPS Growth
- ICCM N/A
- NMTC N/A
- EPS
- ICCM N/A
- NMTC N/A
- Revenue
- ICCM $2,787,000.00
- NMTC $6,629,051.00
- Revenue This Year
- ICCM $3.95
- NMTC $151.98
- Revenue Next Year
- ICCM $266.15
- NMTC $31.96
- P/E Ratio
- ICCM N/A
- NMTC N/A
- Revenue Growth
- ICCM N/A
- NMTC 69.00
- 52 Week Low
- ICCM $0.53
- NMTC $0.40
- 52 Week High
- ICCM $1.66
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- ICCM 36.08
- NMTC 40.08
- Support Level
- ICCM $0.80
- NMTC $0.81
- Resistance Level
- ICCM $0.90
- NMTC $1.15
- Average True Range (ATR)
- ICCM 0.09
- NMTC 0.08
- MACD
- ICCM -0.01
- NMTC -0.02
- Stochastic Oscillator
- ICCM 7.49
- NMTC 3.47
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.